Inventor · disambiguated record
Willard Lew
Also filed as: LEW WILLARD
15 granted patents·13 pending applications·416 citations·filing 1995–2024
95Inventor score
Files withGILEAD SCIENCES INC15CANALES EDA4ALLEN DARIN3SUNESIS PHARMACEUTICALS INC3CLARKE MICHAEL O'NEIL HANRAHAN1
Top patents by PatentIndex Score
28 records- 0195US5763483ACarbocyclic compoundsGILEAD SCIENCES INC·Filed 1996·Granted Jun 9, 1998·70 cites·7 claims
- 0294US8884030B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Nov 11, 2014·29 cites·18 claims
- 0393US8524764B2Inhibitors of Flaviviridae virusesCANALES EDA·Filed 2011·Granted Sep 3, 2013·29 cites·20 claims
- 0492US11344565B2Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2015·Granted May 31, 2022·19 cites·19 claims
- 0592US8536187B22,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infectionsCANALES EDA·Filed 2009·Granted Sep 17, 2013·25 cites·23 claims
- 0690US8513298B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2011·Granted Aug 20, 2013·14 cites·2 claims
- 0790US6111132ACompounds and methods for synthesis and therapyGILEAD SCIENCES INC·Filed 1998·Granted Aug 29, 2000·45 cites·36 claims
- 0889US6878743B2Small molecule inhibitors of caspasesSUNESIS PHARMACEUTICALS INC·Filed 2002·Granted Apr 12, 2005·38 cites·43 claims
- 0988US8569302B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2010·Granted Oct 29, 2013·14 cites·20 claims
- 1086US9321753B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Apr 26, 2016·8 cites·19 claims
- 1186US5866601ACarbocyclic compoundsGILEAD SCIENCES INC·Filed 1995·Granted Feb 2, 1999·39 cites·31 claims
- 1285US5952375ACompounds and methods for synthesis and therapyGILEAD SCIENCES INC·Filed 1996·Granted Sep 14, 1999·53 cites·8 claims
- 1384US2025100999A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1476US2022354873A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 1574US7601725B2Thienopyrimidines useful as Aurora kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2005·Granted Oct 13, 2009·3 cites·21 claims
- 1671US6225341B1Compounds and methods for synthesis and therapyGILEAD SCIENCES INC·Filed 1999·Granted May 1, 2001·21 cites·2 claims
- 1767US2014200188A12'-fluoro substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2014·Application pending·0 cites
- 1866US2020197422A1Methods for the preparation of ribosidesGILEAD SCIENCES INC·Filed 2019·Application pending·0 cites
- 1961US2017226140A12' fluoro substituted carba-nucleoside analogs for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 2060US2012107274A12'-fluoro substituted carba-nucleoside analogs for antiviral treatmentCLARKE MICHAEL O'NEIL HANRAHAN·Filed 2011·Application pending·0 cites
- 2156US2010179123A1Thienopyrimidines useful as aurora kinase inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2252US2014030223A1Inhibitors of flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 2349US2004053999A1Novel compounds and methods for synthesis and therapyFiled 2003·Application pending·0 cites
- 2447US2008207683A1Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin sALLEN DARIN·Filed 2008·Application pending·0 cites
- 2546US5958973APolyhydroxy benzoic acid derivatives and their use as neuraminidase inhibitorsGILEAD SCIENCES INC·Filed 1995·Granted Sep 28, 1999·9 cites·4 claims
- 2646US2009118274A1Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin sALLEN DARIN·Filed 2008·Application pending·0 cites
- 2746US2008269241A1Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin sALLEN DARIN·Filed 2008·Application pending·0 cites
- 2831US2005176758A1Novel compounds and methods for synthesis and therapyFiled 1996·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Willard Lew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →